Di-(5-methylhexyl)phthalate


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:16249068IVR4500 mg/L 4500 mg/LDecreased spleen weightsImmunological endocrine-mediated perturbations
IVR4500 mg/L 4500 mg/LAffects anogenital distance in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR4500 mg/L 4500 mg/LIncreased liver weightsHepatic endocrine-mediated perturbations
IVR100 mg/kg 100 mg/kgIncreased liver weightsHepatic endocrine-mediated perturbations
IVR750 mg/kg 750 mg/kgAnophthalmiaDevelopmental endocrine-mediated perturbations
IVR750 mg/kg 750 mg/kgChanges in ovarian morphologyReproductive endocrine-mediated perturbations
IVR750 mg/kg 750 mg/kgAffects skeletal developmentDevelopmental endocrine-mediated perturbations
IVR750 mg/kg 750 mg/kgAffects testis developmentDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR750 mg/kg 750 mg/kgIncreased liver weightsHepatic endocrine-mediated perturbations
IVR750 mg/kg 750 mg/kgAffects survival of live fetusReproductive endocrine-mediated perturbations
IVR300 mg/kg 300 mg/kgIncreased liver weightsHepatic endocrine-mediated perturbations
IVR8000 mg/L 8000 mg/LAffects anogenital distance in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR8000 mg/L 8000 mg/LIncreased liver weightsHepatic endocrine-mediated perturbations
IVR8000 mg/L 8000 mg/LDecreased spleen weightsImmunological endocrine-mediated perturbations
IVR1000 mg/L -No significant effects observed-
PMID:21633115IVR300 mg/kg/day 300 mg/kg/dayDecreased testosterone levelsReproductive endocrine-mediated perturbations
IVR600 mg/kg/day 600 mg/kg/dayDecreased testosterone levelsReproductive endocrine-mediated perturbations
IVR900 mg/kg/day 900 mg/kg/dayDecreased testosterone levelsReproductive endocrine-mediated perturbations
IVR100 mg/kg/day -No significant effects observed-

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.